Mandate

VINGE ADVISES CREADES IN CONNECTION WITH ITS LISTING ON NASDAQ OMX STOCKHOLM’S MAIN MARKET

December 05, 2013

Creades AB (publ) (NASDAQ OMX First North) has been approved for listing on NASDAQ OMX’s main market. The first day of trading was 6 December 2013.

Vinge’s team primarily consisted of partner Erik Sjöman and associates Jo-Anna Nordström, Christian Lindhé and Rikard Lindahl. Associates Maria Schultzberg and Maria Doeser advised in relation to tax matters.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025